CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Anixa Biosciences, Inc. - ANIX CFD

2.99
0.67%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.23
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.97
Open* 2.94
1-Year Change* -1.67%
Day's Range* 2.9 - 3.04
52 wk Range 2.50-6.25
Average Volume (10 days) 64.75K
Average Volume (3 months) 1.10M
Market Cap 143.18M
P/E Ratio -100.00K
Shares Outstanding 30.92M
Revenue N/A
EPS -0.40
Dividend (Yield %) N/A
Beta 0.96
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 29, 2022 2.99 0.05 1.70% 2.94 3.08 2.90
Jun 28, 2022 2.97 -0.04 -1.33% 3.01 3.14 2.95
Jun 27, 2022 3.16 0.15 4.98% 3.01 3.19 3.01
Jun 24, 2022 3.04 0.07 2.36% 2.97 3.12 2.97
Jun 23, 2022 3.13 0.11 3.64% 3.02 3.19 3.02
Jun 22, 2022 3.18 0.21 7.07% 2.97 3.18 2.97
Jun 21, 2022 3.08 0.06 1.99% 3.02 3.19 3.02
Jun 17, 2022 3.00 -0.16 -5.06% 3.16 3.16 2.96
Jun 16, 2022 3.10 0.15 5.08% 2.95 3.18 2.90
Jun 15, 2022 3.08 0.29 10.39% 2.79 3.15 2.79
Jun 14, 2022 2.88 -0.18 -5.88% 3.06 3.09 2.82
Jun 13, 2022 3.07 -0.18 -5.54% 3.25 3.31 3.04
Jun 10, 2022 3.33 -0.10 -2.92% 3.43 3.48 3.27
Jun 9, 2022 3.48 0.07 2.05% 3.41 3.68 3.41
Jun 8, 2022 3.50 0.23 7.03% 3.27 3.54 3.27
Jun 7, 2022 3.38 -0.49 -12.66% 3.87 3.91 3.30
Jun 6, 2022 3.92 -0.27 -6.44% 4.19 4.44 3.87
Jun 3, 2022 3.94 0.16 4.23% 3.78 3.96 3.61
Jun 2, 2022 3.81 0.01 0.26% 3.80 3.85 3.74
Jun 1, 2022 3.69 0.18 5.13% 3.51 3.70 3.37

Anixa Biosciences, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0.5125 0 0.25 1.1125
Revenue 0 0.5125 0 0.25 1.1125
Total Operating Expense 13.875 13.6482 9.9782 12.14 15.4016
Selling/General/Admin. Expenses, Total 7.172 7.0735 5.597 5.66283 6.91183
Research & Development 6.703 6.18969 4.38121 5.47343 6.81304
Depreciation / Amortization 0 0.41875 0.3253
Unusual Expense (Income) 0 0.385 0 0.585 1.35139
Other Operating Expenses, Total
Operating Income -13.875 -13.1357 -9.9782 -11.89 -14.2891
Interest Income (Expense), Net Non-Operating 0.104 0.00232 0.03392 0.07135 0.04597
Net Income Before Taxes -13.771 -13.1279 -10.0924 -11.8187 -14.2431
Net Income After Taxes -13.771 -13.1279 -10.0924 -11.8187 -14.2431
Net Income Before Extra. Items -13.595 -12.9544 -10.0184 -11.647 -13.996
Net Income -13.595 -12.9544 -10.0184 -11.647 -13.996
Income Available to Common Excl. Extra. Items -13.595 -12.9544 -10.0184 -11.647 -13.996
Income Available to Common Incl. Extra. Items -13.595 -12.9544 -10.0184 -11.647 -13.996
Diluted Net Income -13.595 -12.9544 -10.0184 -11.647 -13.996
Diluted Weighted Average Shares 30.374 28.5789 22.229 19.7898 17.6243
Diluted EPS Excluding Extraordinary Items -0.44759 -0.45329 -0.45069 -0.58854 -0.79413
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -0.44759 -0.44 -0.44403 -0.55898 -0.71745
Total Adjustments to Net Income 0
Minority Interest 0.176 0.17352 0.07401 0.1716 0.24706
Gain (Loss) on Sale of Assets 0 0.00545 -0.14808
Oct 2022 Jul 2022 Apr 2022 Jan 2022 Oct 2021
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 3.609 2.797 3.589 3.88 4.07704
Selling/General/Admin. Expenses, Total 1.924 1.352 1.854 2.042 1.9038
Research & Development 1.685 1.445 1.735 1.838 2.17324
Unusual Expense (Income) 0 0 0 0 0
Operating Income -3.609 -2.797 -3.589 -3.88 -4.07704
Interest Income (Expense), Net Non-Operating 0.08 0.022 0.001 0.001 0.00055
Net Income Before Taxes -3.529 -2.775 -3.588 -3.879 -4.07105
Net Income After Taxes -3.529 -2.775 -3.588 -3.879 -4.07105
Minority Interest 0.053 0.029 0.044 0.05 0.05778
Net Income Before Extra. Items -3.476 -2.746 -3.544 -3.829 -4.01327
Net Income -3.476 -2.746 -3.544 -3.829 -4.01327
Income Available to Common Excl. Extra. Items -3.476 -2.746 -3.544 -3.829 -4.01327
Income Available to Common Incl. Extra. Items -3.476 -2.746 -3.544 -3.829 -4.01327
Diluted Net Income -3.476 -2.746 -3.544 -3.829 -4.01327
Diluted Weighted Average Shares 30.764 30.451 30.152 30.125 30.0451
Diluted EPS Excluding Extraordinary Items -0.11299 -0.09018 -0.11754 -0.1271 -0.13357
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.11299 -0.09018 -0.11754 -0.1271 -0.13376
Gain (Loss) on Sale of Assets 0 0.00545
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 36.0034 9.36862 6.09312 5.53837 7.01394
Cash and Short Term Investments 35.7279 9.05706 5.84163 5.05589 6.83937
Cash & Equivalents 29.1283 6.41706 3.49163 3.05589 3.33937
Short Term Investments 6.5996 2.64 2.35 2 3.5
Prepaid Expenses 0.27556 0.30933 0.18497 0.17549 0.17457
Total Assets 36.2574 9.45296 6.29369 6.44854 8.81242
Property/Plant/Equipment, Total - Net 0.25396 0.05434 0.20057 0.07267 0.0527
Property/Plant/Equipment, Total - Gross 0 0.29558 0.12647 0.08843
Accumulated Depreciation, Total 0 -0.09502 -0.0538 -0.03573
Intangibles, Net 0 0.8375 1.74578
Total Current Liabilities 1.27053 1.18859 1.48132 1.26511 0.88949
Accounts Payable 0.1362 0.23237 0.58582 0.58201 0.48032
Accrued Expenses 1.13433 0.95622 0.8955 0.6831 0.40917
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 0.8201 0.69161 1.05834 1.01373 0.88949
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.22008 0
Total Equity 35.4373 8.76136 5.23535 5.43481 7.92292
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.30051 0.24249 0.20332 0.18909 0.16603
Additional Paid-In Capital 239.927 200.354 186.849 175.416 163.931
Retained Earnings (Accumulated Deficit) -204.79 -191.836 -181.817 -170.17 -156.174
Total Liabilities & Shareholders’ Equity 36.2574 9.45296 6.29369 6.44854 8.81242
Total Common Shares Outstanding 30.0509 24.2487 20.3318 18.9086 16.6028
Total Preferred Shares Outstanding 0 0 0 0 0
Total Receivables, Net 0.00223 0.06653 0.30699
Accounts Receivable - Trade, Net 0.00223 0.06653 0.30699
Minority Interest -0.67051 -0.49698 -0.42298 -0.25138
Other Long Term Assets, Total 0 0.03
Apr 2022 Jan 2022 Oct 2021 Jul 2021 Apr 2021
Total Current Assets 32.563 34.994 36.0034 37.052 38.472
Cash and Short Term Investments 32.231 34.53 35.7279 36.622 38.1027
Cash & Equivalents 27.732 29.781 29.1283 27.2222 27.7034
Short Term Investments 4.499 4.749 6.5996 9.39978 10.3993
Prepaid Expenses 0.332 0.464 0.27556 0.43001 0.36921
Total Assets 32.797 35.238 36.2574 37.0624 38.4975
Property/Plant/Equipment, Total - Net 0.234 0.244 0.25396 0.01041 0.02557
Other Long Term Assets, Total 0 0 0
Total Current Liabilities 1.189 1.787 1.27053 1.20802 1.44287
Accounts Payable 0.093 0.504 0.1362 0.20773 0.43801
Accrued Expenses 1.096 1.283 1.13433 1.00029 1.00486
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 0.626 1.275 0.8201 0.5953 0.88376
Total Long Term Debt 0 0 0 0 0
Minority Interest -0.765 -0.721 -0.67051 -0.61273 -0.55911
Total Equity 32.171 33.963 35.4373 36.4671 37.6138
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.302 0.301 0.30051 0.2995 0.3145
Additional Paid-In Capital 244.032 242.281 239.927 236.944 233.742
Retained Earnings (Accumulated Deficit) -212.163 -208.619 -204.79 -200.777 -196.443
Total Liabilities & Shareholders’ Equity 32.797 35.238 36.2574 37.0624 38.4975
Total Common Shares Outstanding 30.1547 30.1323 30.0509 29.9499 31.4499
Other Liabilities, Total 0.202 0.209 0.22008
Total Preferred Shares Outstanding 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -13.1279 -10.0924 -11.8187 -14.2431 -5.00899
Cash From Operating Activities -4.93688 -6.17567 -4.74143 -4.2734 -3.79671
Cash From Operating Activities 0 0.03828 0.04756 0.01844 0.04322
Amortization 0 0.41875 0.3253 0.3253
Non-Cash Items 8.1125 4.33743 6.1325 9.55825 0.43553
Changes in Working Capital 0.07855 -0.45901 0.47842 0.0677 0.40824
Cash From Investing Activities -3.91768 -0.30579 -0.52546 1.4616 -2.73519
Capital Expenditures 0 -0.01579 -0.17546 -0.0384 -0.03019
Other Investing Cash Flow Items, Total -3.91768 -0.29 -0.35 1.5 -2.705
Cash From Financing Activities 31.5658 9.4069 5.70262 2.52832 7.38295
Financing Cash Flow Items 0.01403 0
Issuance (Retirement) of Stock, Net 31.5658 9.4069 5.68858 2.52832 10.3829
Net Change in Cash 22.7112 2.92544 0.43574 -0.28348 0.85105
Cash Interest Paid 0.00182 0.03989 0 0.27243
Issuance (Retirement) of Debt, Net 0 -3
Apr 2022 Jan 2022 Oct 2021 Jul 2021 Apr 2021
Net income/Starting Line -7.467 -3.879 -13.1279 -9.05688 -4.66927
Cash From Operating Activities -3.503 -1.197 -4.93688 -3.89271 -2.41195
Cash From Operating Activities 0 0 0
Non-Cash Items 4.12 2.364 8.1125 5.26318 2.06069
Cash Interest Paid 2 1 0.00182 0.00168 0.0014
Changes in Working Capital -0.156 0.318 0.07855 -0.09901 0.19663
Cash From Investing Activities 2.1 1.85 -3.91768 -6.72434 -7.72385
Capital Expenditures 0 0 0
Other Investing Cash Flow Items, Total 2.1 1.85 -3.91768 -6.72434 -7.72385
Cash From Financing Activities 0.007 0 31.5658 31.4222 31.4222
Financing Cash Flow Items 0 -2.54893 -2.54893
Issuance (Retirement) of Stock, Net 0.007 0 31.5658 33.9711 33.9711
Net Change in Cash -1.396 0.653 22.7112 20.8051 21.2864
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.2268 1307142 7144 2022-12-31 LOW
Titterton (Lewis H Jr) Individual Investor 2.5031 774070 0 2023-01-17 LOW
UBS Financial Services, Inc. Investment Advisor 2.0131 622544 853 2022-12-31 LOW
Kumar (Amit) Individual Investor 1.4943 462100 0 2023-01-17 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9353 289238 -2985 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.887 274289 3626 2022-12-31 LOW
Long Focus Capital Management LLC Hedge Fund 0.5358 165701 0 2022-12-31 MED
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3302 102100 0 2022-12-31 LOW
Baskies (Arnold M) Individual Investor 0.3234 100000 0 2023-01-17 LOW
Susquehanna International Group, LLP Investment Advisor 0.2297 71023 31115 2022-12-31 MED
Raymond James & Associates, Inc. Research Firm 0.185 57217 -3629 2022-12-31 LOW
Newton Investment Management North America, LLC Investment Advisor 0.179 55350 0 2022-12-31 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1777 54948 0 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.1582 48925 -714 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.1549 47900 -9300 2022-12-31 HIGH
Citadel Advisors LLC Hedge Fund 0.1536 47506 27896 2022-12-31 HIGH
Gottschalk (Emily) Individual Investor 0.1477 45665 0 2023-01-17 LOW
BNY Mellon Asset Management Investment Advisor 0.1367 42268 -238 2022-12-31 LOW
Cambridge Investment Research Advisors, Inc. Investment Advisor 0.1297 40100 25100 2022-12-31 LOW
Corecap Advisors Inc Investment Advisor/Hedge Fund 0.1171 36209 -1177 2022-12-31 MED

Start a global, multi-asset portfolio with an award-winning platform

Trade now Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Anixa Biosciences, Inc. Company profile

About Anixa Biosciences Inc

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing therapies and vaccines that are focused on oncology and infectious disease. The Company is developing chimeric endocrine receptor T-cell technology, a chimeric antigen receptor T-cell (CAR-T) technology focused on treating ovarian cancer, and anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. It is also developing vaccine against triple negative breast cancer (TNBC), the lethal form of breast cancer, and a vaccine against ovarian cancer. Its CAR-T technology can be used as a treatment against multiple solid tumor types. The Company’s segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, Cancer Diagnostics activities, and Patent Licensing activities. Its subsidiary Certainty Therapeutics, Inc. (Certainty), is developing immuno-therapy drugs against cancer.

Financial summary

BRIEF: For the three months ended 31 January 2022, Anixa Biosciences Inc revenues decreased from $513K to $0K. Net loss increased 73% to $3.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Stock-based Compensation in R&D increase from $290K to $1.3M (expense), Stock-based Compensation in SGA increase of 55% to $1.1M (expense), Marketing .

Equity composition

Common Stock $.01 Par, 2/11, 240M auth., 165,877,988 issd.Insiders control 19.03%. Public Offering 10/83, 600K shares @ $10 by Gilford Securities. 6/96 & 3/91, 2-for-1 stock splits; 8/87, 5-for-4 stock split; 11/85, 3-for-1 split. 06/15, 1-for-25, Reverse Stock Split.

Industry: Biotechnology & Medical Research (NEC)

3150 Almaden Expy Ste 250
SAN JOSE
CALIFORNIA 95118
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

28,066.75 Price
+2.640% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 66.00

US100

12,694.00 Price
+0.500% 1D Chg, %
Long position overnight fee -0.0241%
Short position overnight fee 0.0018%
Overnight fee time 21:00 (UTC)
Spread 1.8

Oil - Crude

73.85 Price
+0.310% 1D Chg, %
Long position overnight fee -0.0153%
Short position overnight fee -0.0066%
Overnight fee time 21:00 (UTC)
Spread 0.03

XRP/USD

0.55 Price
+3.800% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00517

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading